drugset / Trial / NCT00376454
The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study was to determine the analgesic effect of GW493838 in patients with post-herpetic neuralgia or peripheral nerve injury caused by trauma or surgery.
Timeline
- Start
- 2002-11
- Primary completion
- 2003-06
- Completion
- 2003-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GW493838 | Small molecule | 50 mg | — |